Shares in Western Australia's biggest biotechnology stock, pSivida Ltd, have risen 7 per cent following news that its Retisert product, licensed to Bausch & Lomb, will be co-promoted in the United States by Novartis Ophthalmics.
10/02/2006 - 10:27
pSivida's Retisert to be co-promoted in the US
10/02/2006 - 10:27
